🇬🇧 NovoCure Limited
Forum topic · NVCR · Company page: financials, ownership and filings
Join the discussion on NovoCure Limited
Loading…
Results announced on 29 October 2026
NovoCure Limited announced results on 29 October 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $193 million (up 16% from a year earlier) and a net loss of $10 million.
Mutual funds: 187 funds hold $572 million
187 mutual funds in 2 countries hold shares of NovoCure Limited worth $572 million, about 30.9% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 106 funds added shares and 53 sold; on balance they bought $33 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.